
6th Inflammatory Skin Disease Summit: The Translational Revolution
Key Takeaways
- The summit will explore breakthroughs in inflammatory skin diseases, focusing on translating research into clinical practice.
- Topics include advances in immunology, molecular mechanisms, and targeted therapies for conditions like psoriasis and atopic dermatitis.
Join leading experts at the 2025 Inflammatory Skin Disease Summit to explore groundbreaking research and innovations in dermatologic care and therapies.
The 6th Inflammatory Skin Disease Summit: The Translational Revolution is a unique and dynamic international symposium, taking place at The New York Academy of Medicine, New York, USA, on November 12–15, 2025. This landmark event will gather leading scientists, clinicians, and researchers to explore the latest breakthroughs in inflammatory skin diseases and their translation from bench to bedside.
The summit will feature an exceptional scientific program covering advances in immunology, molecular mechanisms, and targeted therapies across conditions such as psoriasis, atopic dermatitis, vitiligo, alopecia areata, and beyond. Through plenary lectures, expert panel discussions, and interactive sessions, the meeting will highlight how translational research is transforming understanding, diagnosis, and management of chronic inflammatory skin disorders.
By fostering collaboration between basic science and clinical innovation, the 2025 summit underscores the global commitment to improving patient outcomes and redefining the future of dermatologic care. It stands as a premier forum for advancing knowledge, shaping clinical practice, and driving the next generation of therapeutic breakthroughs in inflammatory skin disease.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.



















